End-stage renal disease in Fabry disease

被引：0
|
作者：
Granata, A.
Romeo, G.
Gulisano, S.
Leonardi, G.
Romano, R.
Manca, E.
Fiumara, A.
Sicurezza, E.
机构：
[1] Vittorio Emanuele Hosp, Dept Nephrol & Dialysis, Catania, Italy
[2] Vittorio Emanuele Hosp, Dept Ophthalmol, Catania, Italy
[3] Vittorio Emanuele Hosp, Dept Cardiol, Catania, Italy
[4] G Brotzu Hosp, Dept Nephrol & Dialysis, Cagliari, Italy
[5] Univ Catania, Dept Paediat, I-95124 Catania, Italy
来源：
CLINICAL THERAPEUTICS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0149-2918(07)80127-5
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] End-stage renal disease in patients with Fabry disease
    Obrador, GT
    Ojo, A
    Thadhani, R
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : S144 - S146
  • [2] MORTALITY IN PATIENTS WITH FABRY DISEASE AND END-STAGE RENAL FAILURE
    Karovaikina, Ekaterina
    Moiseev, Sergey
    Bulanov, Nikolay
    Moiseev, Alexey
    Kuchieva, Agunda
    Fomin, Viktor
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 371 - 371
  • [3] Enzyme replacement therapy in patients with Fabry disease and end-stage renal disease
    [J]. Nature Clinical Practice Nephrology, 2007, 3 (10): : 525 - 526
  • [4] End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry
    Ortiz, Alberto
    Cianciaruso, Bruno
    Cizmarik, Marta
    Germain, Dominique P.
    Mignani, Renzo
    Oliveira, Joao Paulo
    Villalobos, Jacobo
    Vujkovac, Bojan
    Waldek, Stephen
    Wanner, Christoph
    Warnock, David G.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (03) : 769 - 775
  • [5] Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease
    Pastores, Gregory M.
    Boyd, Ellen
    Crandall, Kerry
    Whelan, Alison
    Piersall, Linda
    Barnett, Natalie
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (07) : 1920 - 1925
  • [6] Fabry's disease presenting with oligoanuric end-stage renal failure
    Sirvent, AE
    Enriquez, R
    Antolin, A
    Cabezuelo, JB
    Teruel, A
    Ledesma, JMR
    Gonzalez, C
    Reyes, A
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (07) : 1503 - 1505
  • [7] Screening for Fabry disease in male patients with end-stage renal disease in western France
    Vigneau, C.
    Germain, D. P.
    Larmet, D.
    Jabbour, F.
    Hourmant, M.
    [J]. NEPHROLOGIE & THERAPEUTIQUE, 2021, 17 (03): : 180 - 184
  • [8] Atypical variant and an indirect diagnosis of Fabry disease in a patient with end-stage renal disease
    Ciabattini, F.
    Bordoni, E.
    Guerrini, E.
    Scarfone, V.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 : S26 - S27
  • [9] Prevalence of end-stage renal failure in patients diagnosed with Fabry disease
    Franco, A.
    Torras, J.
    Torra, R.
    Valverde, V.
    Herrera, J.
    Pintos-Morell, G.
    Paniagua, J.
    Gomez, E.
    Torregosa, V.
    Hernandez, S.
    West, M.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2009, 47 : S137 - S138
  • [10] End-stage Renal Disease
    Abbasi, Maaz
    Chertow, Glenn
    Hall, Yoshio
    [J]. AMERICAN FAMILY PHYSICIAN, 2010, 82 (12) : 1512 - 1514
12345